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Abstract
Background: With the broad availability of effective medications, identifying individuals bearing a higher risk for
osteoporotic fractures has become an issue of major concern in modern medicine. In recent years various prognostic
instruments have become available showing conflicting results regarding estimated risks for individual patients.
Objective: To provide an overview of current evidence and of opportunities for further research.
Methodology/Principal Findings: Systematic Review: We identified studies describing the development of instruments and
all subsequent validations in electronic databases and reference lists of included studies. We screened for inclusion, read full
papers and extracted data on salient clinical features, performance characteristics and quality in duplicate. Searches
retrieved 5,275 records of which full texts of 167 papers were obtained after screening titles and abstract. We included 35
studies enrolling a total of 609,969 patients (median 2546) reporting on 31 derivations and 12 validations after assessing full
texts. Median follow-up time was 4.1 years (IQR 3 to 7.7). Only four studies validated an instrument that was developed by
another group. None of the existing instruments was validated more than once. The five most frequent included variables in
the final model were age, body mass index, bone mass index, past history of falls, and maternal history of fractures. The
methodological quality of the studies was moderate.
Conclusion: There is a plethora of evidence available studying the association of risk profiles and the development of
osteoporotic fractures. The small number of out-of-sample validations, the large variety of study characteristics, outcomes
and follow-up periods impedes from deriving robust summaries and from conclusions regarding the clinical performance of
many tools. First and foremost, future activity in this field should aim at reaching a consensus among clinical experts in
respect to the existing instruments. Then we call for careful validations and expedient adaptations for local circumstances of
the most promising candidates.
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Introduction
Osteoporotic fractures are a major cause of morbidity in the
elderly and a considerable burden to health care services.
Fractures necessitate hospitalizations in many cases and result in
loss of function and autonomy of elderly people. Derived from
present data it has been forecasted that 20% of 50-year old men
and half of 50-year-old women will suffer from at least one clinical
fracture during their remaining lifetime [1]. In Switzerland, the
direct and indirect costs spent in caring for one patient with hip
fracture is about 70.000 CHF (about 70.000 US $).
Preventive measures to reduce fractures therefore have high
priority. Various lifestyle modifications and drugs have shown to
reduce the decline in bone mineral density and the risk of osteoporotic
fractures. An efficient strategy would be to identify persons with a
moderate or high risk of fractures who might benefit from preventive
or therapeutic measures. Measurement of bone mineral density alone
may represent an inaccurate predictor of osteoporotic fractures and
most fractures occur in women with normal bone mineral density [2].
A risk prediction rule to estimate the individual future fracture risk
accurately would be helpful. In the last twenty years different risk
prediction rules have been developed, but none of them, like other
predictionrules,hasfoundbroadacceptanceinmedicalpracticesofar.
The purpose of this review was to provide an overview of
current evidence and of opportunities for further research.
Moreover we explored whether setting-up a study developing a
new prognostic instrument for the Swiss population is justified in
light of the existing literature.
Methods
Literature search
In a first phase we searched for derivation studies in the
following databases; Ovid MEDLINE (Ovid version, from
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inception to May 2009). We used the following search terms:
osteoporosis, bone loss, fractures, risk, model, logistic regression,
decision, and validation. The detailed search strategy in Ovid
Medline is available on Table S5. The search was conducted
without restrictions to language or year of publication. We also
hand-searched the bibliography of all studies ordered in full text.
In a second phase, after identifying the original derivation
studies of prediction rules, we used these references to search in
‘‘ISI Web of Knowledge’’ (http://apps.isiknowledge.com) for
corresponding validation studies. This database provides detailed
information on how often and by whom a published paper has
been cited (last access date on May 25, 2009). We assumed that all
validations of an existing prediction rule would cite the derivation
study.
Selection criteria
We included studies describing the development or validation of
prognostic instruments to identify individuals with an increased risk
for osteoporotic fractures. The minimum requirement was that the
study reported the final model, i.e. the selected indicators along with
the strength of association with one of the following outcomes: hip/
femur fracture, vertebral fracture or any/non-vertebral fracture.
Moreover,a studyhadtoprovide a descriptionabout recruitmentof
participants and methods for variable selection.
Study selection
Derivation studies. Two reviewers independently screened
the titles and the abstracts of all retrieved references to identify
derivation studies of prognostic instruments. Full text versions
were ordered for all publications classified by any one of the
reviewers as potentially relevant.
Validation studies. Two reviewers independently screened
the titles and abstracts of all references to identify validation
studies of one of the derivation studies. Full text versions were
ordered for all potentially relevant publications.
Data extraction
We developed article review forms that were pilot tested and
revised before use. The two reviewers independently assessed each
selected study by recording details about study sites, inclusion and
exclusion criteria, number of eligible patients and number of
included patients. In addition, the reviewers recorded the
definitions for various risk factors and outcomes, kind of data
collection (prospective or retrospective) and the statistical method
to derive the prediction rule. We contacted one author of for
further information about missing data but did not get any
response [3].
The two reviewers determined the agreement about data
extraction and final inclusion by consensus. If there was a
disagreement, a third author made the conclusive decision.
Results
In duplicate we screened 5275 records and ordered full texts of
167 papers. In total we included 35 studies reporting on 31
derivations [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,
23,24,25,26,27,28,29,30,31,32,33,34] and 12 validations [8,11,
13,15,23,26,32,33,35,36,37,38] of instruments published between
1990 and 2009. In total 609,969 patients (median 2546,
interquartile range: 1435 to 7654, range: 672 to 197,848) have
been enrolled in the 35 studies. The study selection process is
summarized in Figure 1. Median follow-up time was 4.1 years
(interquartile range 3 to 7.7; range 1 to 15). In five studies duration
of follow up was not reported [6,13,29,30,33]. Only four studies
[35,36,37,38] validated an instrument that was developed by
another group. None of the existing instruments was validated
more than once. We found substantial variation in respect to
variable selection, definition of risk indicators, outcome assessment
and forms of the final model. For details please refer to Table S1.
Assessment of methodological quality
In 29 studies data were collected prospectively [4,5,7,8,9,11,12,
14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,34,35,36,
37], six studies were based on registry data [6,10,13,32,33,38].
Measurement of the outcome, vertebral fractures, was executed
differently; in some studies the rate of vertebral fractures has been
determined on clinical symptoms only [6,8,15,16,18,23,25,31,32,
33,36,37,38], in others by radiography [4,34,35]. In six studies a
random sample of participants were included [4,5,11,14,26,35], in
3 participants were included in a consecutive manner [12,18,32]
and in 17 studies an arbitrary sample has been evaluated
[7,8,9,15,16,19,20,21,22,23,24,25,27,28,31,34,38] and in 9 no
information about inclusion has been reported [6,10,13,15,17,
29,30,33,37]. Variables were defined clearly and clinically sensible
in 34 studies [4,5,6,7,8,9,10,11,12,14,15,16,17,18,19,20,21,22,
23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38]. In general the
quality of the studies was moderate. The details are shown in
Table S2.
Assessed Outcomes
Hip fracture only was the assessed outcome in 12 studies
[7,8,11,16,19,21,22,26,30,34,35,36], non-vertebral fractures only
in 3 studies [12,24,27] and all fractures in 19 studies
[4,5,6,9,10,14,18,20,23,28,29,31,33,37,38]. The details are given
in Table S3.
Statistical methods applied in derivation studies
Logistic regression analysis was the most commonly used
statistical model (n=14) to derive the instrument [4,5,6,7,8,10,17,-
19,23,25,27,28,30,31] and 12 studies used survival models (pro-
portional hazard regression) [11,12,15,18,20,21,22,24,26,32,-
33,34]. A Classification and Regression Tree (CART) algorithm
was used in one study [9] and Poisson regression in another study
[16].
Variables in the final model
The five most frequent included variables in the final model
were age, body mass index, bone mass index, past history of falls,
and maternal history of fractures. Details on all included variables
are given in Table S4.
Discussion
Main findings
Out of 35 studies enrolling more than 600,000 patients only
four studies performed out of population validations of existing
instruments. In many instances details of reporting of model
development, form of the final model, descriptions of calibration,
and discrimination and adjustments were unavailable. The five
most frequent included variables in the final model were age, body
mass index, bone mass index, past history of falls, and maternal
history of fractures.
Strength and Limitations
To our knowledge this is the first comprehensive assessment of
prognostic instruments to identify patients with an increased risk
Risk Assessment for Osteoporotic Fractures
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application of robust systematic review methodology. We believe
that our methods to search, identify and select relevant papers
were sound. We made strenuous efforts to minimize the risk of
selection bias. Relevant reports were searched systematically and
without language restriction. The minimum requirement to be
included in this review was that the study reported the final model,
i.e. the selected indicators along with the strength of association
with hip/femur fracture, vertebral fracture or any/non-vertebral
fracture. The fact that we were unable performing a formal meta-
analysis but were limited to systematic description alone is another
limitation of this study. Study characteristics, outcomes and follow-
up periods ranged substantially and impeded us thus from
providing a statistically robust and clinically meaningful summary.
It may be argued that we did not include an eminent study,
describing the development of the FRAX algorithm. This
exclusion resulted after careful after a lengthy discourse among
the authors. We finally refrained from including the FRAX
algorithm in the study, because it failed to provide the minimum of
information. We think that reports on prognostic models should
Figure 1. Flow of included studies.
doi:10.1371/journal.pone.0019994.g001
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should allow re-calculating estimated risks for an individual
patient. The provision of the model in a web interface is laudable
but no substitute for complete reporting.
Implications for Research
Two issues emerge from this review. The time has come for
clinical experts to reach consensus about the validity of the existing
evidence. We propose Delphi-type consensus studies that allow
securing experts views on the correct type and form of input into
these models. Once this has been assessed the available
instruments should be checked against this consensus. If no
instrument fulfilling the expert consensus exists, the international
societies and other relevant healthcare bodies should set the
research agenda for a well designed, carefully executed and validly
analysed primary study. Researches should execute the studies
carefully and provide an optimal reporting. Second, the models
should be adapted to local circumstances, e.g. by careful
calibration. Finally, impact studies should assess the transfer value
of these instruments in practice.
Conclusion
There is a plethora of evidence available studying the
association of risk profiles and the development of osteoporotic
fractures. The small number of out-of-sample validations, the large
variety of study characteristics, outcomes and follow-up periods
impedes from deriving robust summaries and from conclusions
regarding the clinical performance of many tools. First and
foremost, future activity in this field should aim at reaching a
consensus among clinical experts in respect to the existing
instruments. Then we call for careful validations and expedient
adaptations for local circumstances of the most promising
candidates.
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